HOUSE 863116th CongressReferred to the House Committee on Energy and Commerce.
DXM Abuse Prevention Act of 2019
- Last Action
- 1/30/2019
Actions
- 2019-01-30Referred to the House Committee on Energy and Commerce.
- 2019-01-30Introduced in House
- 2019-01-30Introduced in House
CRS Summary
As of 2019-01-30 (00)
DXM Abuse Prevention Act of 2019
This bill addresses the sale and distribution of dextromethorphan (DXM).
Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.
The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
Cosponsors (3)
- Bill Johnson (R-OH)
- Yvette Clarke (D-NY)
- RON KIND (D-WI)
Subjects
- Child health
- Civil actions and liability
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Licensing and registrations
- Prescription drugs
- Retail and wholesale trades
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.